The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis.

Ao, Guangyu; Wang, Yushu; Li, Anthony; Tran, Carolyn; Yang, Qing

Ao, Guangyu; Wang, Yushu; Li, Anthony; Tran, Carolyn; Yang, Qing.

Ao G; Department of Nephrology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
Wang Y; Chengdu West China Clinical Research Center, Chengdu, Sichuan, China.
Li A; School of Medicine, Queen's University, Kingston, Canada.
Tran C; Schulich School of Medicine and Dentistry, Western University, London, Canada.
Yang Q; Department of Cardiology, West China Hospital, Sichuan University, No.37 Guoxue Lane, Wuhou District, Chengdu, Sichuan 610044, China. Electronic address: qingyang@scu.edu.cn.

J Infect ; 84(6): 834-872, 2022 06.

Article in English | MEDLINE | ID: covidwho-1739957

Subject(s)

COVID-19 Drug Treatment; Antibodies, Monoclonal, Humanized/therapeutic use; Humans; SARS-CoV-2

Keywords

COVID-19; Canakinumab; Mortality; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Reviews Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.03.011

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google